Back
Eli Lilly and 10K Form
Sell
40
LLY
Eli Lilly and
Last Price:
747.82
Seasonality Move:
3.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LLY News And Ratings
See the #1 stock for the next 7 days that we like better than LLY
LLY Financial Statistics
Sales & Book Value
| Annual Sales: | $34.12B |
|---|---|
| Cash Flow: | $-458.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $15.82 |
| Price / Book: | 49.99 |
Profitability
| EPS (TTM): | 9.25000 |
|---|---|
| Net Income (TTM): | $8.37B |
| Gross Margin: | $27.04B |
| Return on Equity: | 66.4% |
| Return on Assets: | 12.55% |
Eli Lilly and Earnings Forecast
Key Eli Lilly and Financial Ratios
- The Gross Profit Margin over the past 40 years for LLY is 79.25%.
- The Selling, General & Administrative Expenses for LLY have been equal to 20.34% of Gross Profit Margin.
- The Research & Development expenses have been 27.29% of Revenue.
- The Interest Expense is 9.27% of Operating Income.
- The Net Earning history of LLY is 15.36% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 23 years.
Eli Lilly and Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LLY |
| CUSIP: | 532457 |
| Website: | lilly.com |
Debt
| Debt-to-Equity Ratio: | 2.19 |
|---|---|
| Current Ratio: | 1.27 |
| Quick Ratio: | 0.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 129.3 |
|---|---|
| Forward P/E Ratio: | 33.18 |
LLY Technical Analysis vs Fundamental Analysis
Sell
40
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy or a Sell?
-
Eli Lilly and stock is rated a Sell
The current Eli Lilly and [LLY] share price is $749.92. The Score for LLY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.